Cingulate Inc. (CING) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Cingulate Inc. on September 10, 2024, reporting an event that occurred on September 9, 2024. The Company is an emerging growth company incorporated in Delaware with its principal executive offices in Kansas City, KS. Its common stock (CING) and warrants (CINGW) are listed on the Nasdaq Capital Market.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity metrics. This report focuses exclusively on regulatory compliance status rather than financial performance.
Material Changes
The primary material event is the resolution of a listing deficiency. On September 9, 2024, the Nasdaq Hearings Panel determined that Cingulate Inc. has regained compliance with the $1.00 Minimum Bid Price requirement (Nasdaq Listing Rule 5550(a)(2)). This follows a non-compliance notice received on June 17, 2024, and a temporary exception granted on August 2, 2024, which allowed the Company to demonstrate compliance through August 23, 2024.
Outlook, Risks, and Contingencies
While the Company has regained compliance, it remains subject to a discretionary panel monitor through May 21, 2025, pursuant to Nasdaq Listing Rule 5815(d)(4)(A). This monitoring period represents a continuing contingency where the Company must maintain compliance to avoid potential future delisting risks.
Key Facts for Investor Verification
- Confirm the current trading price of CING to ensure it remains above the $1.00 minimum bid price threshold.
- Verify the specific terms of the discretionary panel monitor ending May 21, 2025.
- Review subsequent filings for any updates on the Company's financial health, as this 8-K contains no financial data.
- Monitor the status of the Company's warrants (CINGW) in relation to the common stock listing status.